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THE MATERIAL CONTAINED IN THIS DOCUMENT 
SERVED AS INPUT FOR THE FAO-COMMISSIONED 
STUDY ‘EXCHANGE, USE AND CONSERVATION OF 
ANGR: POLICY AND REGULATORY OPTIONS’ (CGN 
2006/6) (Hiemstra et alia 2006). 
  1 
 
1 Background 
Genetic resources law and policy at the international level, has mostly 
been focused at plant genetic resources for food and agriculture1 and on 
genetic resources and biological diversity in general.2 A literature review 
disclosed that Farm Animal Genetic Resources (AnGR) is only very 
scarcely addressed compared to plant genetic resources (PGR). This does 
not mean that AnGR are less important for food security and nutrition 
since, for example, 30% of total nutrition is covered by food from 
animals. In rural and marginalised areas, livestock contributes 70% of the 
livelihood.3 There is a growing interest among the member countries to 
the FAO for the need to address AnGR at the international level. When 
the topic policy and regulatory options for AnGR now comes into 
attention, there is a danger that experiences from the plant sector may be 
directly applied to farm animals.4 Policy and regulatory options should, 
however, be adapted to the special circumstances for the animal sector 
and avoid a ‘copy-paste approach’ from the plant sector, if those 
solutions are not found adequate for the animal sector. 
2 The Subject Matter – Farm Animal Genetic 
Resources 
2.1 Differences between Plants and Animals 
A point of departure for a policy and regulator analysis is to develop a 
clear understanding of the subject matter that is up for discussion. Since 
the body of policies and regulations mainly have been developed in the 
plant sector, it is interesting to compare these two sectors to identify simi-
larities and differences relevant for policy making and regulation. At first 
sight plant breeding does not differ much from animal breeding. Plant 
and animal breeding are similar in that they need genetic diversity in 
order to advance, and that the genetics determine adaptation to particular 
agro-ecological and product qualities to a large extent. 
However, marked differences do exist. While plant breeders aim at 
development of new varieties to replace old varieties and that may be 
protected by plant breeders’ rights, farm animal breeding is largely based 
on selection of individuals within populations based on a continuum of 
genetic material rather than complete shifts to a new breed. The farm 
animal breeders are interested in individual animals and populations, 
                                                     
1
 The Food and Agriculture Organisation, Commission on Genetic Resources for 
Food and Agriculture and the International Treaty on Plant Genetic Resources 
for Food and Agriculture (IT-PGRFA), and the CGIAR; there is also a 
substantial body of literature relevant for plant genetic resources. 
2
 Convention on Biological Diversity (CBD); the World Intellectual Property 
Rights Organisation (WIPO), in particular the Intergovernmental Committee on 
Genetic Resources, Traditional Knowledge and Folklore (IGC) and the WTO-
TRIPS. 
3
 FAO, 1999 LID, 1999. 
4
 For a comparison of plant and farm animal genetic resources, see below. 
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while a plant variety is the main focus of plant breeders. Maintaining 
genetic variation within populations and minimizing inbreeding is much 
more relevant in farm animals than for plants. 
Although an individual animal might carry unique gene combinations or 
new mutations, in contrast to the situation with many plant species, ex-
ploiting the unique genetic characteristics of an individual animal is cur-
rently extremely difficult due to long generation intervals, low repro-
duction rates, high cost of evaluating the genetic characteristics of a sin-
gle animal and the absence of effective use of recombinant gene techno-
logy in the animal sector. The unit of diversity in AnGR is, therefore, 
generally considered to be a population of animals, often referred to as a 
breed.5 The animal breeding sector largely concentrates on the diversity 
within populations; the costs are often too high to introduce exotic mate-
rials into a genetic background required for modern farming due to long 
generation intervals and small numbers of offspring. This marks a 
difference, as for plants the introduction of a new gene may be less 
costly.  
Biological differences clearly require different approaches to conserva-
tion, breeding and use. Compared to plants, fecundity and reproductive 
capacity is extremely low in farm animals, although there are substantial 
differences between species. Also, collection, storage and distribution of 
seeds are easier for plants. Due to the differences in creating genetic 
progress and its dissemination, the management of genetic resources is 
more complicated for animals than for plants.6 
In plants, intensification of crop production has generally been accompa-
nied by emergence of a strongly institutionalized and centralized genetic 
resources sector dominated by publicly funded national and international 
centres in addition to collections held by private firms. Institutional 
capacity for AnGR conservation is limited, with only a few existing 
public sector national ex situ collections and none under the auspices of 
FAO. These are not involved in large-scale exchange or breeding 
programs. Ownership of AnGR is perceived to almost exclusively reside 
in the private sector.  
Costs to collect, cryopreserve and subsequently reconstitute AnGR germ-
plasm are many times greater per preserved genome than costs to collect, 
store and subsequently utilise seeds. This is one important reason why 
AnGR conservation has much more heavily emphasized in situ conser-
vation. One advantage for conservation of AnGR is that cryoconserved 
gametes will remain viable in perpetuity and do not require viability tests 
or replanting and harvesting programs, and thus the costs of maintenance 
of cryoconserved stock are low. 
                                                     
5
 Gibson and Pullin 2005. 
6
 Notter 2004. 
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Table 1 Biological, Technical and Institutional Differences between 
Plant and Farm Animal Genetic Resources 
Factor Plant genetic resources Farm animal genetic 
resources 
Mendelian segregation Yes Yes 
Self pollination Yes No 
Asexual reproduction / clonal 
propagation Yes No, only artificial 
Crossbreeding Yes, between inbred lines Yes, between selected lines 
Inbreeding Yes No, not desirable 
Genetic modifications Possible and efficient Possible, hardly accepted 
Generation interval Low < 1 year High 1 up to 8 years 
Number of offspring  High Small number up to high 
number 
Economic value individual or 
germplasm Low Moderate to high 
Phenotyping costs production 
(individual/family) Very low to low High to very high 
Phenotyping costs adaptation, 
resistance (individual/family) Very low to moderate Very high 
Cost of breed/variety testing Inexpensive Expensive 
Status of in situ genetic 
conservation Promoted Promoted 
Status of in vivo ex situ 
conservation Minor role Major component 
Status of gene banks 
Extensive collections 
(important role of 
CGIAR*) 
Semen collections in 
developed countries (no 
involvement of CGIAR*) 
Technical feasibility of ex situ 
(in vitro) conservation For majority of species 
Semen ok for majority of 
species 
Conditions for storage In cool conditions Only liquid nitrogen 
Ease and costs of 
extracting/testing accessions 
from gene banks 
Generally easy and 
relatively low cost 
Difficult, costly and/or 
time consuming (often 
several generations 
backcrossing) 
Ongoing collection of 
indigenous/wild germplasm Still significant Very little activity 
Costs of collection Low High to very high 
State of global databases Relatively advanced databases 
Country controlled data in 
FAO database 
* Consultative Group on International Agricultural Research 
Source: Adapted from Gibson and Pullin (2005) 
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The organisation of the animal breeding sector differs significantly 
among animal species. The commercial breeding industry for poultry, pig 
and dairy cattle is as concentrated as in major crops, whereas commercial 
large scale interest in other species is minimal and left to livestock keep-
ers themselves. In developing countries animal breeding programmes are 
often less developed than those for plants. 
Finally, the centres of diversity for AnGR are not as clearly defined as for 
plants. South-North exchange is very limited; North-South exchange is 
high and South-South exchange is becoming more important. It seems 
that the entering into force of the CBD has hardly influenced the 
exchange of AnGR so far. In plants, implementation of the International 
Treaty on Plant Genetic Resources for Food and Agriculture (IT-PGRFA) 
relies heavily on the institutions of the seed sector that were already 
heavily involved in the international movements of germplasm. In 
contrast, the global movement of AnGR is already limited by strict 
sanitary regulations designed to protect health of national herds, and by 
high costs of movement, testing and development. Collection and testing 
of AnGR from the developing world is therefore less frequent. 
Even if there are some similar features between plants and animals, the 
differences are substantial and require caution when drawing a parallel 
between them for regulatory purposes. These differences need to be 
reflected in the policy and regulatory options for AnGR.  
2.2 The Term ‘Animal Genetic Resources’ 
The term ‘Animal Genetic Resources’ (later referred to as AnGR) is used 
to describe the subject matter. The term is used in a very practical manner 
and applied scope referring to all uses of animals for breeding purposes. 
The term ‘breeding purposes’ is also used in a broad sense, covering a 
number of different methods applied in the livestock sector. The main 
element of AnGR is the genetic material of animals used in further 
breeding and in the production of food and industrial products. This 
covers semen and eggs, embryos and live animals when they are being 
used for breeding purposes. Genetic material also refers to DNA 
molecules, RNA, proteins and other micro-physical genetic material. The 
term AnGR is used in a practical manner and does not focus on the 
informational elements of ‘genetic resources’.  
The differences between farm animals and plants, identified above, need 
to be reflected in the legal analysis. In the farm animal sector there is yet 
another important component, the techniques and methods for breeding 
and husbandry. This does not fall under the term ‘genetic resources’ as 
such but is important to have in mind when discussing law and AnGR. 
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2.3 The Concept ‘Genetic Resources’ in the CBD 
The Convention on Biological Diversity (CBD) uses the term ‘genetic re-
sources’ in a rather specific meaning.7 The definition of the term is 
derived from two definitions specifically included in the Convention: 
‘Genetic resources’ means genetic material of actual or potential 
value.8  
‘Genetic material’ means any material of plant, animal, microbial 
or other origin containing functional units of heredity.9 
Read together ‘genetic resources’ include any material of plant, animal, 
microbial or other origin containing functional units of heredity of actual 
or potential value. This indicates that all biological material is source or 
origin for ‘genetic resources’.10 A necessary condition is that the origin is 
biological. The term ‘any material of … animal’ is broad and covers ani-
mals, even though regulating animal breeding is not the main aim of the 
CBD. This is however only the first delimiting criterion for determining 
when the obligations and rights apply according to the CBD. The term 
‘genetic resources’ is used in the CBD to establish a new category of 
resources: When value and benefits are drawn from biological material in 
particular manners, these manners are defined by the two criteria: 
• containing functional units of heredity 
• actual or potential value 
The term ‘containing functional units of heredity’ is the first delimiting 
criterion for determining whether one is under the scope of the obli-
gations in CBD Article 15. The term functional units of heredity is not 
defined in the convention, but is generally thought to refer to DNA, RNA 
and proteins derived therefrom. This formulation points towards parts 
(units) of the material that are related to the hereditability of the organ-
isms. It is important to note that the definition is not linked to the units of 
heredity as sciences described them in 1992 or even today; the wording 
does not use the term gene or DNA-molecule. It has been formulated in a 
technology-neutral manner making the scope of the obligations according 
to CBD Article 15 flexible, covering the use also when technologies shift 
and develop in the future, so other as-yet-unknown components will be 
embraced by the definition. In recombinant gene technology all these 
parts of biological material are of direct interest. Although technological 
difficulties and consumer opinion do not allow as yet for commercial 
development of Genetically Modified-animals (GM-animals) this might 
become the reality in the near future, so the regulatory and policy options 
must take them into account. Some species, e.g. farmed fish are near such 
developments, which emphasises the need for law to be robust. Thus, 
genetic material as a legal concept is linked to the part of the biological 
material which is subject to any heritable interest beyond the biological 
                                                     
7
 For a through discussion of the term, see Tvedt 2006, at p. 194–197. 
8
 CBD Article 2, section 10. 
9
 CBD Article 2, section 9. 
10
 CBD Article 2 tenth section read in conjunction with ninth section. 
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properties of the organisms where it once was found. From a practical 
perspective the obvious example in animal breeding is that semen, eggs, 
fertilised eggs and embryos are expressions of and contain genetic 
material.  
One difficult question arises when for example a calf is sold. It could be 
sold as a breeding male and it could be sold to be fed and slaughtered (or 
a combination of these), and it may also be used to extract DNA for 
industrial or agricultural inventions. The young calf is surely carrying 
functional units of heredity and consequently genetic material. Farm 
animal breeding is characterised by such multiple purpose use. Sales of 
an individual, e.g. a calf could entail both sales for the purpose of feeding 
and slaughtering as well as the intention of using it as a breeding animal 
(either in pure breed or in cross-breeding aiming at introducing certain 
characteristics into the other breed).  
The next delimiting criterion in the CBD is that the genetic material must 
have ‘actual or potential value’. The focus of this criterion and thus the 
definition of genetic resources is at the value that arises from uses cap-
turing the value of the genes.11 This includes breeding seeking to improve 
the properties of the next generation of animals, for example disease 
resistance, higher lactation or better meat quality. The CBD establishes a 
special concept of resources, the use of genetic material for taking 
advantage of the genes as a resource. The concept ‘genetic resources’ in 
the CBD is closely related to the benefit-sharing obligations of the CBD. 
The benefit-sharing obligation according to the CBD is focused on 
sharing ‘the benefits arising out of the utilization of genetic resources’12 
and ‘the results of research and development and the benefits arising 
from the commercial and other utilization of genetic resources’.13  
Common for these formulations is that they are geared towards the 
utilisation rather than the access to or export of biological material, seek-
ing to capture a part of the value created by the use of the genetic material 
to be shared back to providers and conservers of biological diversity. The 
legal concept ‘genetic resources’ according to the CBD could therefore 
be understood as including all activities that result in capturing the 
‘actual or potential value’ of genetic material by taking advantage of the 
‘functional units of heredity’.  
It is suggested by Tvedt and Young that in the process of making the term 
‘genetic resources’ operational in a legal system based on the CBD, three 
elements of resources should be included:  
1. The micro-physical genetic material, when the user is aiming at 
drawing benefits from the genetic material and not from the bulk 
value of biological material; 
2. The intangible genetic information; 
                                                     
11
 Tvedt 2006 and Tvedt and Young 2007 forthcoming. 
12
 CBD Article 1 (emphasised here). 
13
 CBD Article 15.7 (emphasised here). 
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3. Any combination of the micro-physical/tangible genetic material 
and the genetic information. 
This dual understanding of genetic resources is an important step for the 
successful implementation of the objectives of the CBD. For the animal 
sector the informational elements are also extremely important. Know-
ledge about the breeding value of an animal, or specific traits that it 
carries, is of crucial value for breeders. Knowledge takes various forms, 
from systematic archives on pedigree (herdbooks), performance data and 
medical history to more dispersed informal or traditional expressions of 
knowledge. We, however, concentrate on AnGR in a narrower sense, 
focusing mainly on the physical elements of ‘genetic resources’, not on 
the related knowledge. 
2.4 Available Legal Tools Relevant for AnGR 
In the area of AnGR international, regional, and national law along with 
customary law are relevant. Animal breeding happens within the territory 
of one country. Therefore, the point of departure for breeders, farmers 
and livestock keepers is the national legislation of their country. 
Multinational breeding companies relate to the national laws in all the 
countries where they conduct business. Since food production is 
increasingly an international area and market, there is also a web of 
relevant regional and global agreements. In the field of genetic resources 
a substantial amount of law-making goes on at the international arena and 
at a regional level. International and regional law may be totally new (e.g. 
CBD) or target harmonisation of national laws (e.g. veterinary 
regulations). This leaves legal analyses in a schizophrenic situation of 
whether to focus on national or international law. For AnGR, elements 
from both are particularly interesting, so the focus of the analyses shifts – 
we need to keep an eye on both the national and international level. 
There are no comprehensive international regulations or policies that 
specifically address the management, sovereignty, ownership and benefit 
sharing for AnGR.14 It has been noted that ‘AnGR lag behind plant 
genetic resources at the international level’ and there are also very few 
countries that have policy frameworks explicitly for managing AnGR 
among other genetic resources.15 There are, however, several interna-
tional treaties with a general scope applying to AnGR.16 The Convention 
on Biological Diversity (CBD) establishes sovereign rights over ‘genetic 
resources’, which implies that a country has the right to regulate various 
aspects regarding the resource, inter alia property rights to it. The 
sovereign rights do, however, not automatically include a property right 
for the state or government, and they go together with the obligations of 
signatory countries to conserve and promote sustainable use.  
                                                     
14
 Gibson and Pullin, 2005. 
15
 FAO, 2005. 
16
 The Convention on Biological Diversity, the Agreement on Trade-Related 
Intellectual Property Rights under the World Trade Organisation and the patent 
system as maintained by a number of agreements under the World Intellectual 
Property Organisation, the WIPO. 
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Four different areas/angles are interesting to discuss under the current 
regulatory framework regarding the effect on exchange, use and conser-
vation: 
• Ownership and exclusive rights to AnGR (section 3); 
• Exchange, access and benefit sharing related to AnGR (section 4); 
• Sanitary issues related to exchange of AnGR (section 5). 
The overall objective of this analysis is to contribute to the development 
of options for international law to respond to current needs and future 
developments in AnGR (section 6). 
3 Ownership and Exclusive Rights in Animal 
Breeding 
One topic which is increasingly relevant is that of exclusive rights or 
property rights to genetic material, even though the literature discussing 
AnGR is still scarce.17 Several types of law are relevant for exercising 
exclusive rights pertaining to AnGR: 
1. Property rights to or ownership of individual animals or populations 
of animals; 
2. Contracts for transferring property rights or ownership;  
3. Intellectual property rights created to protect novel developments or 
inventions (non-physical or intangible values). 
3.1 Property Rights – Ownership of the Individual Animal 
For farm animals and thus also AnGR, private ownership is the rule and 
the public domain the exception. The point of departure and main rule is 
that the owner of the individual animal has the right to use the genetic 
resources in further breeding. This ownership to AnGR is seldom speci-
fied in legislation and is most often based upon customary law. For farm 
animals there are strong biological and physical means of protection 
available:18 The owner of the animal can more easily than the plant 
breeder have an overview and control over who is receiving genetic 
material from his animals or his population. This physical control, 
however, diminishes for secondary use and subsequent generations. The 
case is different for poultry and pig breeding where farmers often buy 
hybrids whose genetics are more difficult to reproduce. The sale of 
hybrids is thus an important strategy for maintaining physical control 
over the genetic material by physical control over the material. For other 
breeds, in particular cattle, the physical ownership is often combined with 
a register, a herd book that maintains a protocol for the generations of 
animals fulfilling the criteria for registration. 
                                                     
17
 See for example the Nordic Council of Ministers 2003:19. 
18
 For a discussion of the parallel situation for fish, see Rosendal 2006, at p. 398 
sig. 
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Property right or ownership is often understood as a bundle of rights – a 
set of actions which the ‘owner’ has the exclusive right to exercise. 
Ownership of one single animal or a population covers inter alia the right 
to: 
• breed the next generation of individuals (use of genetic material); 
• sell the animal (can be exchange of genetic material); 
• sell its products (if semen is sold for artificial insemination (a.i.) 
it will be exchange of genetic resources), or; 
• slaughter it and use or sell the products (which would be equal to 
destructing genetic material). 
Ownership of an animal includes, as a point of departure, all these types 
of use of the animal. This is considered to be fairly obvious by farmers 
and breeders as well as policy makers. It becomes more complex when 
the concept ‘genetic resources’ is taken into account including different 
levels of rights, as some of these actions draw benefits from the genetic 
material of the individual rather than the biological material.  
Animal keepers and breeders continuously upgrade their breeding stock, 
sell animals or genetic material or disseminate genetic progress within a 
company. Improved traits are passed to further generations by various 
breeding techniques. This may imply that extra cash flow from the im-
proved genetic material flows back to the subsequent genetic improve-
ment programmes or to the owners of the breeding animals.  
These property rights are seldom explicitly regulated in an act. There are 
no international agreements specifying anything about property rights. It 
is the national level that is the source of law for property rights, as it is 
the nation state which has the power to safeguard and maintain the 
property rights within its borders. As ownership is seldom regulated in an 
act, this issue is solved by various forms of customary rights. It is widely 
recognised that for a norm to be regarded as international customary law, 
three conditions must be fulfilled: 
1. To become customary law there must be a continuing practice over a 
certain period of time; 
2. The practice must be fairly consistent by the relevant entities (states 
for international customary law and persons within each legal 
system); 
3. It must have been followed as it was a binding norm, so-called 
opinion juris. 
The fact that the ownership of the individual animal and the right to use it 
in breeding has been the practice in the complete history of animal hus-
bandry and breeding; this practice has also probably been consistent in 
the sense that no comprehensive legal systems/general legal regulations 
have been departing from the right of the owner of the animal to use its 
genetic material. It can be expected that farmers have followed this pract-
ice as a legally binding norm (opinion juris) to the extent that this issue 
has been thought of in legal terms over a long period. This might be 
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considered as obvious by the majority of farmers or policy makers. The 
fact that this legal point of departure is viewed as fairly obvious to all 
relevant stakeholders strongly indicates that this is a well established 
customary law.  
When a norm is recognised as customary law, delimitations in the right 
must be justified. If any limitations exist, they need to be based either on 
the consent by the owner (contract) or by legislation (by parliaments) 
altering the customary law. The holder of the right to animals can, inter 
alia, be a private person, a cooperative or it can be a group of persons or a 
community of livestock keepers. The general principle applies that there 
are no legitimate or legal limitations in the property right over the genetic 
material from the animals under the ‘ownership’ by a community. To 
fully conclude on the issue of ownership one must analyse the legal 
sources of each country.  
3.2 Contractual Agreements: Contracts – Transferring an 
Existing Right to Another Person 
The right to use the animal in breeding is often specified in a (formal or 
informal) contract between the seller and the buyer of an animal. The 
main rule that ownership can be transferred also applies to animals. The 
contract or informal agreement determines the scope of what is trans-
ferred and which rights still belong to the seller (if any). As a contract is 
individually agreed, the seller may keep or reserve himself certain rights 
to the offspring of the animals. The contract then determines which rights 
are transferred to the contracting party. If no reservation is included in the 
terms for the sales, the assumption is that the buyer of the animal receives 
all the rights that the seller had, including taking advantage of the genetic 
resources. If an animal is sold to the slaughter house for the meat value, 
the interpretation of that contract will likely be that the buyer does not 
have a right to use the genetic resources, but only a right to use the meat 
and other products. 
Contracts imply a dynamic element in establishing (or transferring) rights 
from one owner to the other. The point of departure is that the owner can 
transfer what he has the right to, but he cannot transfer more than already 
is covered by his legal right. The contract determines the scope of what is 
transferred and which rights still belong to the seller. A contract is 
individually agreed, and is thus more specific than the general rules of 
ownership. The owner decides whether he or she wants to sell the animal 
or give access to the genetic material by selling e.g. semen, eggs or 
embryos. Thus, the exchange of genetic material is subject to a contract 
between the provider (seller) and the user (buyer), also if the transaction 
is between persons in different countries.  
The value of a contract is closely related to the compliance by others to 
its terms and conditions. Therefore, the potential to use contracts must be 
seen in the perspective of the possibility to enforce others to comply with 
the content of the contract. In a transparent market, where the seller has 
good control over the further use of what he sells, the use of contracts 
will probably be effective. This is for example the case where one needs 
to register the animal in a herdbook for the next generation of animals to 
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become valuable, and the register depends upon the documentation of the 
parents of the young animal.  
The seller of semen could for instance reserve for himself the right to sell 
semen, or reserve for himself a right to the off-spring of the next generat-
ion of calves, to ensure a right to the genetic resources coming out of the 
breeding with his individual. This agreement or contract could be more or 
less formal and more or less standardised. A comprehensive study of 
contractual practice regarding transfer of AnGR has not been undertaken 
yet, and is difficult because such contracts are commonly kept secret.  
An obvious advantage to using contracts is that industry is accustomed to 
this legal tool. Effective contract law including systems for enforcement 
are in place in the majority of countries, increasing the chance for achiev-
ing the content of the agreement. The most important limitation of the use 
of a contact is that it only applies between two parties, and has no legally 
binding effects for third parties. Thus a contract can hardly be binding for 
the next rounds of transfer of the AnGR. A contract may include clauses 
which seek to regulate the subsequent transfer of the genetic material, the 
enforcement of which may only be possible in a highly regulated or 
transparent market, or if an effective tracing system is in place. 
3.3 Introduction to Intellectual Property Rights 
Ownership and contracts are two dimensions of property rights relevant 
to the animal sector. The limitation of these legal tools is the effect in 
relation to third parties. Here various forms of intellectual property rights 
become relevant as these general rights are enforceable upon third parties 
(within the same jurisdiction). By the Agreement on Trade-Related 
aspects of Intellectual Property Rights (The TRIPS) as a part of the 
World Trade Organisation (WTO) in 1994, international harmonisation of 
intellectual property rights were sought by laying down minimum 
requirements for all types of IPRs. Before the TRIPS Agreement the 
scope and extension of intellectual property rights were mostly a national 
issue.  
Four types of intellectual property rights are relevant in the field of 
AnGR: ‘geographical indications, trademarks, trade secrets and pat-
ents’.19 Intellectual property rights are developed to capture revenues 
from intangible resources, for example from knowledge, a brand or an 
invention. Intellectual property rights create a (commonly temporary) 
exclusive right, granted by the government, based on national legislation 
which may be subject to regional or international harmonisation. 
There are two international organisations working in the field of harmoni-
sation of intellectual property rights on a global level: The World Trade 
Organisation and its Trade-Related Aspects of Intellectual Property 
Rights Agreement (TRIPS) and the World Intellectual Property 
Organization (WIPO), which administers a number of treaties. Whereas 
the TRIPS Agreement implied the largest single change in international 
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IPR law, the WIPO represents more of a continuous process on interna-
tional cooperation and harmonisation of intellectual property rights. In 
addition there is a growing number of regional and bilateral agreements 
dealing with IPR. 
Intellectual property rights are not a ‘breeding tool’ or a technique for 
improving the breed. They pertain to the value of a product or a process 
in a market. By introducing a legal tool like intellectual property rights 
into a new sector, the climate for competition and for production may be 
altered. Thus, there is a need for analysing the consequences that this 
introduction has already had and the probable consequences it will bring 
in the future. This has not yet been done for the animal sector. 
The interesting main question for our purpose is what kind of intellectual 
property rights are available for the animal sector? This can be separated 
into three more detailed questions: 
1. Who is the holder of the right (entitled)? 
2. What is the subject matter that is protected by the right? 
3. What is the scope of the right? Or which acts are under the exclusive 
right of the holder of the intellectual property rights? 
3.4 Trademarks  
A trademarks is a ‘sign, or any combination of signs, capable of disting-
uishing the goods or services’ that may add value to a product by disting-
uishing the product from other similar products in the market.20 Trade-
marks offer legal protection of a brand or signs illustrating a brand. The 
TRIPS Article 15 to 21 regulates a minimum level of recognition of 
trademarks required upon all WTO members. Even if the TRIPS obliges 
a large number of countries to provide a high level of minimum protect-
ion, the cooperation in the WIPO is more detailed and plays an important 
law-making role.  
Trademarks are being used to add value to a product by including certain 
intangible elements into a product, for example a famous label that is 
linked to a history of tradition or special methods to bring this specific 
product to a market. The owner of a trademark is the register or the one 
who has created it. The main idea of trademarks is to protect a distinction 
between one product and all other products in the market – for the 
purpose of charging a higher price than competing products. Thus, gene-
tic material per se cannot be protected or covered by a trademark. A 
trademark can, however, be a useful tool in the animal sector as the 
value-adding elements created in breeding can be protected. A trademark 
can improve the value of a product. 
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3.5 Geographical Indications 
Geographical indications can protect ‘indications which identify a good 
as originating in the territory of a Member, or a region or locality in that 
territory, where a given quality, reputation or other characteristic of the 
good is essentially attributable to its geographical origin’. (TRIPS Article 
22, paragraph 1). Similar to trademarks, geographical indications do not 
protect the breed or genetic material per se, but may add commercial 
value to the animals of breed produced in a particular region. Geograph-
ical indications prevent all others than the producers from that original 
location from using that particular geographical indication incorrectly as 
a trademark for other products than those from that area. The essence of 
this intellectual property right is the protection of the combination of a 
territorial name (geographical origin) and ‘a given quality, reputation or 
other characteristic of the good’. Geographical indications do not protect 
or establish any exclusive rights to the genes per se. They may be inter-
esting as a value-adding legal mechanism in the animal sector, if the qual-
ity or reputation of a product is linked to a certain geographical area, and 
commonly linked to the use of particular breeds. Typically, this applies to 
agriculture, i.e. Champagne and Parma. Geographical indications are 
closely interlinked with the protection of trademarks, as a trademark 
should be not be granted if it is based upon a geographical indication 
‘other than the true place of origin in a manner which misleads the public 
as to the geographical origin of the good’ (TRIPS Article 22, paragraph 
2a). 
Box 1 Example of Protected Designation of Origin 
The French production of chicken meat is differentiated as standard broiler 
(SB), label chicken (LB), certified chicken (CF), organic chicken and Pro-
tected Designation of Origin. At the moment the latter category is reserved 
for the Bresse breed only. These chickens, 1.4 million raised per year, are 
produced in the Bresse geographical area only, as defined by law. The pro-
duction is characterized by natural conditions and a production system uni-
que for that area. For the Bresse, the district was defined in 1936 and the 
name ‘Volaille de Bresse’ was protected by law in 1957. The breed has un-
ique phenotypic characteristics. After an initial starting period of 5 weeks a 
fixed set of specific growing conditions (diet, housing) must be applied for 
at least 9 weeks. Specific regulations also apply to slaughtering conditions 
and processing of carcasses. Since 1995, the selection procedure is 
regulated and the final product is a cross of three sub lines obtained after 
mild selection. The price for the chicken is 50-60% higher than for stand-
ard or label chicken. Starting as a threatened breed kept by fancy breeders, 
the Bresse breed became locally a very popular breed yielding high profits. 
Reference: Verrier et al., 2005 
3.6 Trade Secrets 
Trade secrets or ‘Protection of Undisclosed Information’ are regulated in 
TRIPS Agreement Article 39. This can hardly be categorised as an 
intellectual property right as it does not establish an exclusive right over a 
specific subject matter. The character of these obligations is rather related 
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to the protection against unfair competition according to the Paris 
Convention 10bis. The scope of this legal measure is rather narrow and it 
does not provide for exclusive commercial rights to the one seeking to 
hold information secret. Protection of undisclosed information is relevant 
in animal breeding, where commercial breeders want to keep their 
nucleus stock and the pedigree and value information away from com-
petitors. However, protection by trade secret is more difficult to enforce 
than the other rights discussed here. 
3.7 Patents 
A patent grants an exclusive right to the commercial use of a new 
invention either described as a product or a process. Patenting of living 
matter is fairly new in a global context and in the large majority of 
countries, and patenting in the field of animal breeding is a very recent 
phenomenon.21 The watershed court case is the often quoted Diamond vs. 
Chakrabarty from the US Supreme Court in 1980. The question in this 
case was whether one particular genetically engineered bacterium could 
be patented; where the Court formulated the all-sweeping general state-
ment that: ‘anything under the sun that is made by man’ is patentable.22 
This court case has had major impact on the legal situation throughout the 
world as it prepared the ground for altering the basic principle that patent 
protection was not available for life forms.23 The effect of patents on 
research and development in animal breeding is yet insufficiently ex-
plored. The degree to which such protection should extend to plants and 
animals is contentious among countries and there are potential areas of 
incompatibility or overlap with the aims of the Convention on Biological 
Diversity.24 An overall challenge is that patent law operates with general 
concepts originally chosen for promoting technical industrial inventions, 
whereas now the same legal concepts are applied to new fields of tech-
nology which were not thought of being relevant for patent protection.25 
The patent criteria are, according to TRIPS Agreement Article 27, para-
graph 1 that an invention shall be patented if i) it is novel, ii) involves an 
inventive step and iii) have an industrial application (the footnote to the 
paragraph states that the terms ‘non-obvious’ and ‘useful’ can be used 
synonymously). The TRIPSAgreement prescribes that all areas of innova-
tion must be open for patent protection, except some particular types of 
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 In the US, where the expansion of application of patent law is going most 
rapidly, there were according to Lesser a total number of 45 animal patents from 
1995 to 2001 (Lesser 2002, at p. 9). 
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 Diamond v. Chakrabarty, 447 U.S. 303 (1980) Decided June 16, 1980. 
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 The Diamond v. Chakrabarty was referred to by the Canadian Supreme Court 
in Harvard College v. Canada (Commissioner of Patents), the Canadian Onco 
Mouse Case, Neutral citation: 2002 SCC 76.File No.: 28155. 
24
 See for example this issue in the TRIPS Council under the WTO, IP/C/W/368, 
IP/C/W/369, IP/C/W/467–IP/C/W/475. 
25
 For example Westerlund 2001 discusses profoundly the concepts of invention 
or discovery, enabling disclosure and the doctrines of equivalence for biotech 
patents (however focused on plants); and Bostyn 2002 who discusses the 
requirement for enabling disclosure in depth. See also the report from the 
Nuffield Council which expresses several concerns. 
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subject matters, defined in Article 27. The more detailed interpretation 
and application of these criteria is left to be determined by national prac-
tice for each area of innovation.  
A patent is granted by the Patent Office of one country and is valid in the 
territory of that country.26 Patents are territorial, but developments aimed 
at harmonising these national laws are ongoing in the World Intellectual 
Property Organisation. This illustrates that the legal analysis in the field 
of animal breeding needs to reflect the international, regional and national 
level. The focus here is patent law at international level. A multilateral 
forum for discussing topics related to genetic resources and intellectual 
property rights is the Intergovernmental Committee (IGC) on Intellectual 
Property and Genetic Resources, Traditional Knowledge and Folklore 
which was established in 2000.27 The work of the IGC is general in scope 
and does not address AnGR in particular. The outcome from these 
discussions is however going to apply equally to AnGR. Even though the 
IGC has met ten times, it is far from reaching a legally binding treaty on 
these questions.  
Another process of harmonisation of patent law that may have a large 
effect on the animal sector was led by the Standing Committee on the 
Law of Patents (SCP). In the Standing Committee the work aims at 
establishing complete harmonisation of the patent criteria (invention, 
novelty, inventiveness and industrial application) and a number of other 
crucial patent concepts. The general scope of these draft texts is general 
and will apply to the animal breeding sector. The effects from the general 
law on this particular area of innovation are however not at all in focus.28 
In April 2006 the Standing Committee failed to agree upon a future 
working plan for further harmonisation of patent law global in scope. The 
countries in the so called B-Group of the WIPO, mainly the OECD 
countries and a small number of developing countries have decided to 
continue the harmonisation of patent law outside the general fora of the 
WIPO. As the degree of consensus among these countries is higher, they 
are probably going to reach harmonisation of those issues that the 
Standing Committee did not achieve. These harmonised rules will apply 
to the animal sector even if they are not built upon any analysis of how 
these rules are going to affect the sector.  
3.7.1 Patentability According to the TRIPS Agreement 
The question the types of inventions that are eligible for patent protection 
was previously left to the discretion of each country. This was radically 
altered by the TRIPS Agreement, which establishes a comprehensive 
scope of patentability by requiring all member countries to provide for 
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 For the member countries of the European Patent Organisation, a patent can be 
granted for several countries at the same time. There is a similar system 
administered by the OAPI, the African Organisation for Intellectual Property, 
which grants patents that are valid in 16 mainly francophone West African 
countries. 
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 www.wipo.int/tk/en/igc/ 
28
 For an analysis of the effect from this draft for genetic resources in general, 
see Tvedt 2005. 
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patent protection in all fields of invention, save some narrow exemptions: 
Countries are allowed to exempt patent protection of animals other than 
micro-organisms; and for essentially biological processes.29  
The TRIPS Agreement opens for exempting animals other than micro-
organisms from product patent protection in national patent law. The 
practical implications of this exemption depend upon the interpretation of 
the legal concept ‘other than micro-organisms’. There is no definition or 
any agreed understanding of the term micro-organisms among the parties 
to the TRIPS Agreement. Thus, countries have significant discretion as to 
whether to include or exclude animal, animal- proteins, genes and cells 
under patent protection in their national patent system, which may have a 
significant impact on biotechnology. One linguistically possible interpre-
tation of this term is that countries have the freedom to exempt product 
patent protection regarding every category of animal-related biological 
invention except those being clearly recognised as micro-organisms in a 
biological sense. 
The TRIPS agreement obliges all member countries to provide for 
process patent protection to ‘any inventions, whether products or pro-
cessses, in all fields of technology’. The point of departure is that count-
ries are bound to grant process patents also in the field of animal breed-
ing. The TRIPS article 27 paragraph 3 opens for countries to exempt 
‘…essentially biological processes for the production of […] animals’, 
but obliges countries to delimit such an exemption and provide for 
patents to ‘other than non-biological and microbiological processes’. The 
essential question is what is an ‘essentially biological process’? A WIPO 
official, de Carvalho, argues that this wording should ‘… be read in a 
restrictive manner…’ since it is an exclusion and maintains that: ‘…there 
are processes which are biological, to the extent they comprise some 
phase in which biological reproduction is employed, yet their most im-
portant steps consist of acts of human direct interference. These pro-
cesses, in essence, are not biological’ and must therefore, according to 
him, be patentable according to his understanding of the TRIPS Agree-
ment.30 However, the TRIPS agreement does not specify the legal con-
cept further, and countries have a wide discretion to implement a broad or 
narrow definition of essentially biological processes for the production of 
[…] animals. As the wording here is not clear, the TRIPS Agreement 
encompasses a level of discretion for countries in their implementation 
and practice based on this provision. When having determined that coun-
tries have a significant discretion for specifying and establishing exemp-
tions in the eligibility from patent protection, the next step is to look at 
the criteria for the patent to be granted: 
3.7.2 Definition of Prior Art – Criteria for Granting the Patent 
The concept of prior art defines what the patent system regards as 
previously known and thereby not open to be included under patent pro-
tection. The main principle is that what is not novel or does not involve a 
sufficient level of inventiveness cannot be covered by a new patent. In 
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principle, nothing that already is provided to the public shall be patent-
able; it is included under the prior art. This general principle is however 
narrowed down by technical definitions of what the patent system con-
siders to be prior art; and by a technical procedure for searching the 
existing information to determine what is prior art, to find out what was 
already known before a new patent application. The TRIPS Agreement 
does not specify what is included under the prior art. The technical 
definition of prior art was suggestion to be harmonised globally in the 
draft SPLT as: 
The prior art with respect to a claimed invention shall consist of 
all information which has been made available to the public any-
where in the world in any form [as prescribed in the Regulations,] 
before the priority date of the claimed invention.31 
A first look at the wording gives the impression that the definition is 
broad. It includes ‘all information’, ‘available to the public anywhere in 
the world’ and ‘in any form’. This gives an impression of a worldwide 
concept of prior art that in principle excludes everything available to the 
public from patent eligibility. However, to be included under prior art it 
must be conceived as ‘information’ according to the draft Treaty, it must 
be ‘available to the public’ in the manner prescribed by patent law and it 
must be presented ‘in any form’ accepted by the patent system. Hence, 
what appears to be a worldwide, comprehensive definition will be deli-
mitted when made operational in the patent systems. These seemingly 
broad terms are narrowed down in the draft Regulation that goes into 
more detail and specifies the obligations according to the draft Treaty.32 
One challenge regarding the prior art in the field of AnGR is that a lot of 
the best practices are poorly documented. The practice of the definition of 
prior art might thus allow for patents that include some already known 
techniques, but whether this becomes a problem rests in the practice of 
the patent offices. The prior art is used as a basic for the assessment of 
whether the invention is regarded as novel and implies a sufficient level 
of inventiveness. Also these considerations are general ones, but will 
have particular effects in the field of animal breeding.  
3.7.3 Scope of Protection 
The acts covered by a patent are harmonised at the global level for all 
fields of technology by the TRIPS Agreement Article 28:  
A patent shall confer on its owner the following exclusive rights:  
(a) where the subject matter of a patent is a product, to prevent 
third parties not having the owner’s consent from the acts of: 
making, using, offering for sale, selling, or importing for these 
purposes that product; 
(b) where the subject matter of a patent is a process, [it confers a 
right] to prevent third parties not having the owner’s consent from 
the act of using the process, and from the acts of: using, offering 
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for sale, selling, or importing for these purposes at least the 
product obtained directly by that process. 
These acts are formulated in a wide and general manner. To answer the 
question of how patent law will apply to the animal sector, these general 
acts of infringement must be coupled with the typical manners to 
formulate a patent claim. How the scope of patent protection will adhere 
to the field of animal breeding is yet to be observed, as this has not been 
affirmatively determined by any courts yet. Therefore, at the international 
level it is not certain what the legal situation is when it comes to the 
protection conferred by a patent in this field of animal breeding.33  
One fundamental difference between regular industrial inventions and 
those based on naturally occurring biological material is that the 
industrial invention is likely to be man-made from scratch; whereas for 
example a gene is already there in nature, in most cases only in a slightly 
different form. This implies that a product patent relates to something 
already existing in nature. This has a potential to raise difficulties in the 
animal field both in terms of prior art and scope of protection, specifically 
because AnGR is mainly already in private or communal ownership. 
Therefore, there is a latent conflict between the owner of the animal 
genes in the animals and a subsequent patentee.34  
The product patent covers an exclusive right to the use or application of 
the described method. But the scope of protection extends also to cover at 
least the product obtained directly by that process. This means that the 
scope of process patent protection in the TRIPS Agreement indirectly 
requires product patent protection to be covering the outcome from the 
use of a patented method. Using a patented process might therefore give 
the patentee rights to the off-spring from the application of the process. 
The scope of protection in the TRIPS Agreement is not adapted to the 
field of animal breeding – so these consequences are probably not 
foreseen in the WTO. 
3.7.4 Limited Exclusion  
The TRIPS Article 30 opens for members to:  
[…] provide limited exceptions to the exclusive rights conferred by 
a patent, provided that such exceptions do not unreasonably 
conflict with a normal exploitation of the patent and do not 
unreasonably prejudice the legitimate interests of the patent 
owner, taking account of the legitimate interests of third parties. 
This option to provide for limited exemptions in the scope of protection 
has not yet been thoroughly examined in the patent literature. Also the 
limits of which exemptions that are sufficiently ‘limited’ and when they 
do not imply an ‘unreasonable prejudice’ and what is ‘legitimate 
interests’ of the patentee are not clarified by any court or board of appeal. 
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Also not many countries have developed specific exemptions for the field 
of animal breeding or biological patents in general. The EU has imple-
mented a system for exemptions according to this article in the TRIPS.35 
When developing countries call for flexibility in the TRIPS Agreement 
and for their national implementation, one first step could be to explore 
whether the already existing exemptions could be used. 
4 Access and Benefit Sharing Related to AnGR — 
The Convention on Biological Diversity 
The Convention on Biological Diversity (CBD) is broad in scope and 
applies to biological diversity, which is defined as: 
the variability among living organisms from all sources including, 
inter alia, terrestrial, marine and other aquatic ecosystems and the 
ecological complexes of which they are part; this includes divers-
ity within species, between species and of ecosystems.36  
This includes by principle also farm animals. The definition of ‘genetic 
resources’ in the CBD is, as discussed above, a rather specific one. 
According to the CBD all genetic resources are under the sovereign rights 
of the states as part of their sovereign right over natural resources.37 
Sovereign rights include the right to regulate various aspects including 
access to the resources and property rights to them. The general rules as 
explained in the previous section regarding property rights, contracts and 
intellectual property rights are all regulated at the country level, although 
not necessarily explicitly and in detail.  
Beyond the obligations to take a number of conservation measures, the 
CBD establishes the right of countries to develop procedures and 
conditions for access and benefit sharing, often referred to as ABS. Thus, 
access to AnGR from another country could be dependent upon the 
regulations in the country where access is sought. There are however not 
many countries with an effective access legislation in place. The CBD 
prescribes that access could be made subject to prior informed consent 
from the providing country (or parties in the country) before genetic 
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resources legally can be accessed. It also specifies that access should be 
on mutually agreed terms. The further details as to how these two legal 
instruments could be applied are not specified in the CBD. The regulation 
of access is primary dependent upon the regulation in each country. In 
(April) 2002, the Conference of the Parties to the CBD adopted the Bonn 
Guidelines (CBD, 2002), a voluntary set of suggestions to assist govern-
ments and regional bodies to develop policies, legislation and administra-
tive practices to develop access legislation. The main focus in the Bonn 
Guidelines is almost exclusively on measures to be taken in the provider 
country.38 Despite these efforts, there are not many countries claiming to 
have a well-functioning system for access in place. Access is often 
referred to as a contract between the provider country and the user of 
genetic resources. The contractual approach has been used since the CBD 
entered into force in 1993, but there are still not many documented 
examples of contracts. The CBD does not differentiate among the various 
types of organisms, even though the use of genetic resources differs 
among types of species. The little focus on farm animals in the CBD 
could expose the access rules under the CBD to having an undesired 
effect for access to and exchange of AnGR. 
The other side of ABS is a wide set of benefit sharing obligations upon 
users and user countries of genetic resources in the CBD. The more 
detailed implementation of benefit sharing legislation has so far been 
referred to the national level without good guidance from the interna-
tional level, and effective results are still to be seen. Until now there has 
been only a limited focus on how to implement the obligation in CBD 
Article 15, paragraph 7: 
7. Each Contracting Party shall take legislative, administrative or 
policy measures, as appropriate, and in accordance with Articles 
16 and 19 and, where necessary, through the financial mechanism 
established by Articles 20 and 21 with the aim of sharing in a fair 
and equitable way the results of research and development and the 
benefits arising from the commercial and other utilization of 
genetic resources with the Contracting Party providing such 
resources. Such sharing shall be upon mutually agreed terms.  
Despite the clear wording obliging countries to take legislative, admini-
strative or policy measures aiming at sharing benefits in a fair and equi-
table way, user countries have been very reluctant to take any such steps. 
The question of how these obligations can be implemented at the national 
level is now being raised in the Conference of the Parties to the CBD. 
The construction of an international architecture for ABS was given 
further endorsement and impetus by the Plan of Implementation adopted 
at Johannesburg World Summit on Sustainable Development in 
(September) 2002. The CBD COP 7 negotiated a mandate for the so-
called Ad Hoc Working Group on ABS to negotiate an International 
System for ABS. The Ad Hoc Working Group has met twice before the 
COP-8 in 2006, and will meet before the next CBD-COP with the aim of 
presenting concrete results. 
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The CBD recognises that agricultural genetic resources need to be treated 
differently than other forms of biodiversity, but the CBD has not taken 
any initiatives to support a specific focus on AnGR. 
The Commission on Genetic Resources for Food and Agriculture under 
the UN FAO is a forum through which governments can discuss and 
negotiate matters related to genetic resources for food and agriculture. 
The agricultural sector (under the FAO Commission) has sought to pro-
mote access and benefit sharing to plant genetic resources by concluding 
the International Treaty on Plant Genetic Resources for Food and Agri-
culture. The focus of the Commission to date has been on plant genetic 
resources, but it is now moving to address AnGR more systematically. 
5 Sanitary and Veterinary Regulation of AnGR 
Exchange of AnGR is dependent upon regulations of import and export. 
Many countries have developed legislation on the importation of animals 
or breeding stock, setting out detailed and specific requirements on ani-
mal identification and breeding documentation, as well as on the health 
status of imported stock (FAO, 2005). In countries that consider export of 
breeding stock as a commercial enterprise, no export regulations are 
provided by the state. There appears to be an assumption that quality and 
health standards should be laid down by the importing party. On the other 
hand, countries may want to regulate export of breeds or breeding stock 
as a protection measure for their genetic resources. 
Regulation of sanitary issues for AnGR is foremost a topic that is regu-
lated in national legislation. The objective of this type of legislation is to 
protect animal health to prevent the spread of diseases and not to regulate 
exchange of genetic resources. Liberalisation of trade in goods (com-
modities) is identified as an important goal inter alia under the WTO. 
Import restrictions based on animal health can easily imply a hidden bar-
rier to trade. The indirect effect of this might be that the national food 
production is guarded from effective competition from foreign producers. 
The WTO Agreement on the Application of Sanitary and Phytosanitary 
measures (SPS) deals with sanitary (human and animal health) and phyto-
sanitary measures (plant health) that can be applied in the international 
trade in, among others, plant and animal products. The SPS Agreement 
aims at restricting the use of unjustified sanitary and phytosanitary meas-
ures for the purpose of promoting trade. The SPS Agreement encourages 
governments to establish national SPS measures consistent with 
international standards, guidelines and recommendations. This process is 
often referred to as ‘harmonization’. The Office International des 
Epizooties (OIE) is recognized as the standard-setting body for animal 
health. OIE standards are relevant to the management of AnGR in the 
import-export context. 
Legal frameworks are frequently negotiated in political and regional 
groups of countries to improve cooperation, coordinate activities and 
minimise duplication of work. For example, EU sanitary legislation is 
made up of Directives and Regulations which must be implemented at the 
Member State level. Sanitary regulations are currently the most relevant 
(and often restrictive) regulation for exchange between countries within 
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EU and exchange between EU countries and countries outside Europe. In 
many countries there are specific and very strict regulations regarding the 
exchange of live animals in order to protect against the introduction of 
animal diseases in livestock trade (FAO, 2005), while regulations on 
exchange of semen, ova and embryos are usually sufficiently addressed in 
Animal Breeding Law and Veterinary Law. 
6 Current Debate on Regulatory Issues 
In the following sections, potential regulatory measures to address the 
access, exchange, conservation and sustainable use of AnGR are dis-
cussed. There is a considerable amount of overlap between measures 
under the three different areas of challenges, conservation, exchange and 
use of AnGR. In this section the various regulatory approach areas are 
examined in further detail.  
6.1 Increased Breeding Capacity and the Development of 
Breeding Laws 
There are few well organized selection programs based on local/ 
indigenous breeds and it is crucial for the survival of local/indigenous 
breeds for on-going breed improvement to be taking place. Local/indige-
nous breed improvement may also be accompanied by the development 
of controlled cross-breeding programs, depending on specific production 
circumstances and markets. 
Breeding laws serve different purposes. A general objective is to improve 
the quality of breeds or breeding populations and to contribute to the 
conservation of breeds. It is generally accepted that breed associations or 
herd books play a prominent role in breed development and breed con-
servation, as they will promote maintenance and improvement of quality 
of pure breeds. Breed associations should spearhead the official perform-
ance and pedigree recording of the animals belonging to the respective 
breeds. Use of trademarks or geographical indications could also protect 
registered breeds. Many countries have breeding laws and regions might 
also aim at harmonization of national regulations (e.g. the cross border 
recognition of breed associations/herd books in the EU). Further harmon-
ization of breeding laws would facilitate exchange and could contribute 
to livestock sector development and possibly also to breed conservation. 
Potential disadvantages that would have to be overcome include the fact 
that the establishment of herd books or recognized breed associations 
could result in trade barriers, as they could be used to block the import of 
non-registered breeds and breeds from countries where the particular 
regulations do not apply.  
6.2 Regulation of Import 
Exchange of AnGR between countries has contributed positively to breed 
and livestock sector development in the past. However, there have also 
been direct or indirect negative effects on farm animal genetic diversity. 
Intensification of production systems and the importation of high output, 
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commercial breeds can constitute threats to other (local) breeds in the 
importing countries. Countries should consider implementing genetic im-
pact assessments before importing AnGR. Impact (both positive and 
negative) assessments could also be extended to include economic and 
livelihood impacts, as well as other developmental and/or environmental 
impacts. Potential risks of Living Modified Organisms (LMOs), as well 
as food safety issues, are likely to become a major issue if and when 
genetic modification becomes widespread in the livestock sector.  
The advantage of implementing impact assessments is the expected re-
duction of unwanted introgression or breed replacement. It creates strong-
er responsibilities for both exporters and importing countries and it has a 
direct effect on the conservation of local resources.  
Potential disadvantages that would have to be overcome include the fact 
that the impact assessment requirements of importing countries may 
result in more bureaucracy, thereby blocking imports and reducing live-
stock sector development opportunities. From a regulatory perspective it 
would be necessary to ensure that impact assessments do not unduly 
constitute a barrier to trade. There are also additional costs involved in 
the realization of impact assessments, including for monitoring and miti-
gation activities. Institutional and technical capacity would also have to 
be strengthened. Although the development of genetic impact assess-
ments have been discussed in the literature for a number of years, to the 
authors’ knowledge no actual methodological development has yet taken 
place. Drawing heavily on the genetics and environmental impact assess-
ment literatures, a methodology that assessed introgression and breed 
substitution risks based on, inter alia, a range of crossbreeding scenarios 
(from controlled to uncontrolled) and differentiated by production 
systems and socio-economic factors, would first have to be developed 
and tested.  
Although the obligation to carry out a (genetic) impact assessment could 
be regulated at national or international levels, such an activity would 
clearly benefit from support from the international community. This 
would help ensure that a widely applicable model/standard impact assess-
ment instrument could be developed. 
Exporter/importer impact assessment responsibilities could be phrased 
either in terms of binding (national or international) regulations or by the 
development and implementation of a ‘code of good practice’. Where 
voluntary approaches might be expected to function well, these might be 
preferred. For both voluntary and binding approaches, the quality of the 
assessment would have to be assessed by an appropriate institution (e.g. 
in the importing countries or in conjunction with an independent insti-
tution).  
6.3 Regulation of Export  
The CBD presupposes the right of a country to exercise sovereign control 
over its AnGR (accompanied by a number of responsibilities). From the 
perspective of an exporting country, one of its main concerns is to main-
tain any property rights it may wish to retain over the AnGR after the 
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resources have left the country. Similarly, it may wish to ensure that the 
rights of the exporter are respected by the buyer/importer of the AnGR. 
The most prominent rationale for a country to regulate export of AnGR 
would be to secure a right over that particular material in the future, 
including preventing that countries or companies gain control over these 
resources (e.g. through patenting or other forms of intellectual property 
rights), which might reduce the value of it in the exporting country.  
A second rationale for regulating the export of genetic resources has been 
the expectations of benefit sharing arising out of the use of genetic reso-
urces. However, it is a difficult task to determine any exact future econo-
mic value and potential monetary benefits may be substantially lower for 
AnGR than for plant genetic resources in general (see Table 1 for key dif-
ferences between AnGR and PGR). Nevertheless, one should keep in 
mind the fact that current international AnGR research already involves 
considerable non-monetary benefit sharing with national institutions and 
livestock keepers, in terms of information exchange, technology transfer, 
training, joint research and development, and institutional capacity 
building.  
Furthermore, it can be argued that private parties agree on benefit sharing 
elements when farm animal genetic material is being transferred by a pri-
vate law agreement. Particularly in the commercial breeding sector, pri-
vate law contracts often include payment not only for the purchase of the 
animal but also for any subsequent use of the genetic resource for breed-
ing purposes. The level of payment for breeding material will typically be 
determined by the market positions of the buyer and the seller. In well 
functioning markets one can expect that a ‘fair’ price is reached. How-
ever, where negotiation capacities and market position are inequitable, 
intervention may be required to ensure that a fair price is actually agreed 
upon. In such a context, an export regulation could provide a useful sup-
plementary tool for private law agreements. Such a regulation would set 
rules or a minimum standard for the content of a private law agreement to 
be considered legal or valid, thereby regulating the sale of AnGR/breed-
ing material to another country/private entity.  
From the perspective of the CBD, an interesting question is whether it is 
relevant for a country to require its prior informed consent for each cross-
border transaction of AnGR. Access laws are often accused of being too 
bureaucratic and to block the exchange of genetic resources rather than 
promoting their access, although there is little documented evidence of 
this. A general observation is that if there is a need for authorizing the 
export of AnGR, the particular country should have a clear objective in 
mind. A system for prior informed consent does not necessarily need to 
be a bureaucratic one. It can be as simple as conferring a duty to register 
transactions so that the exporting country collects better information 
about its gene flow or to distribute certain benefits back to the provider of 
the genetic material. Such systems might facilitate access in international 
trade in AnGR rather than restricting it. A register could also contribute 
to increasing traceability later, in particular for the purpose of detecting 
diseases, or in determining sources of origin for any future property 
claims. Where a system of prior informed consent is connected to a bene-
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fit sharing obligation (monetary or otherwise) then it could also generate 
support for conservation, use and livelihoods.  
6.4 Model or Standard Material Transfer Agreements 
Currently, questions arise under the CBD regarding access to genetic 
resources and the fair and equitable sharing of the benefits arising from 
the use of these new types of resources. Those questions also apply to 
AnGR, although the discussion itself has been mainly dominated by wild 
biodiversity and plant genetic resources. Stakeholders are in general hap-
py with current exchange practices, although some notable exceptions 
exist and it is also clear that uncontrolled exchange can sometimes nega-
tively affect farm animal genetic diversity. At the same time, future sce-
narios suggest that an increasing number of problems may arise in the 
future and therefore it is important to develop specific (voluntary or bind-
ing) policies or regulations, which best deal with the risks and problems 
currently or likely to be in the future associated with AnGR exchange. 
As noted in previous sections, cross-border transfer of AnGR is often 
protected through the use of private law agreements. From a regulatory or 
policy point of view such private law guided exchange could be supple-
mented by a standard or model Material Transfer Agreement (MTA) 
which would supplement or replace the fragmented use of contracts 
today. The use of a standard MTA could supplement or replace the 
existing private law MTA and could be a response to unequal negotiating 
capacity and the market dominance of larger entities in the commercial 
livestock sector, helping to level the playing field. One alternative is 
therefore to develop an international standard MTA that regulates the de-
sired aspects of the transfer of AnGR. A number of different formats may 
be useful:  
• Legally binding multilateral agreement aiming at governing all 
transactions; 
• Standard or model MTA; 
• MTA guidelines or check list; 
• Code of conduct. 
All these formal expressions of a common level for the regulation of 
exchange of AnGR could be developed both at a multilateral and at a 
regional level. A binding agreement under international law would be the 
most onerous for countries; it would probably guarantee the highest level 
of harmonisation among countries, but would also be the hardest to reach 
consensus about. Other alternatives have in common that they are less 
onerous in a purely legal sense and might end up in being more effective 
given the additional flexibility that could be built in. Although non-
binding alternatives are just that, i.e. non-binding, when private parties 
use such standards within a private law agreement they become legally 
binding inter parties. Similarly, non-binding alternatives at the internat-
ional level could be implemented, if so desired, within national policies 
or law in a more binding manner. This could be achieved, for example, if 
countries chose to impose an obligation upon importers and/or exporters 
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of AnGR to use a specific standard MTA or a contract similar to a model 
MTA.  
A further issue relates to which topics/issues such a standard MTA should 
address and how difficult issues could be solved by the use of an inter-
national standard or model. A general observation is that such a standard 
needs to include perspectives of both the exporters and importers. The 
content of such a standard could cover, inter alia, the following: 
• Characteristics of AnGR 
• Transfer prices 
• Transfer conditions 
• Use restrictions 
• Supplementary benefit sharing agreement 
The main advantage of a standard MTA is that it could reduce the tran-
saction costs and time needed for negotiating every transfer individually 
and may also support the establishment of a more balanced legal relation-
ship between two unequal parties. Development of a standard tool would 
need to start with a detailed review of existing contractual practises. The 
standard MTA could be evaluated regularly based on experiences with 
this tool. 
6.5 Bilateral Exchange Agreements 
The common contractual private law practice (i.e. regulating relationships 
between individual private parties) for AnGR operates in a context of 
public law (i.e. regulating relationships between individual private parties 
and the state). Countries could therefore decide to develop a bilateral 
framework agreement aiming at facilitated exchange of AnGR, following 
a pre-negotiated set of rules. The bilateral framework agreement could 
cover national policies related to the export and import of AnGR includ-
ing sanitary standards; and countries could adapt the agreement to speci-
fic conditions (‘mutually agreed terms‘). A standard bilateral agreement 
would fit very well into the system under the CBD, whereby countries are 
given the authority to grant prior informed consent for access to genetic 
resources. It could also regulate the responsibilities of both exporting and 
importing parties, taking on board elements of genetic impact assess-
ments. A bilateral approach could be developed in conjunction with a 
standard MTA. Similar advantages may also be achieved by stimulating 
stakeholders to discuss a code of conduct for AnGR exchange. 
Discussions on voluntary guidelines for Access and Benefit Sharing have 
resulted in the Bonn Guidelines (CBD, 2002). If countries are to enter 
into bilateral agreements, it is important to analyse which elements from 
the CBD and the Bonn Guidelines are relevant for AnGR and adapt them 
to this particular context. A legally binding international regime for ABS 
is currently under discussion under the auspices of the CBD. The out-
come from this process could affect AnGR, and thus it is important to 
have the specific needs and challenges of AnGR in mind when develop-
ing general law under the CBD. A particularly adapted bilateral exchange 
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agreement for AnGR could also contribute to the general CBD discussion 
and minimize any negative effects from newly developed general rules. 
6.6 Measures in Patent Law 
Patent law is general in scope, applying to all fields of technology and 
innovation. Consequently, it does not necessarily take into account the 
specific needs and challenges of AnGR or the breeding sector. The main 
legitimacy of this existing legal framework rests in its contribution to 
innovation, research and development. If the intellectual property right is 
not contributing to increased research and development, time-limited 
monopolies can hardly be justified. The concern for AnGR is that a high 
number of claims, as is common for patent applications, may lead to the 
establishment of a significant body of exclusive rights with substantial 
impact upon the use of AnGR by researchers, breeders and farmers. The 
potential consequences are yet to be seen.  
In the plant breeding sector, the main rule is that PGR are in a public 
domain open to use by everyone. This is different for AnGR which are 
often in individual or communal private ownership. It may well be that 
the need for maintaining a viable public domain for AnGR is not as 
important as for plants. However, if patent protection is granted with a 
low requirement of inventiveness and novelty (potential examples are in 
fact in the process of being granted), and if granted broadly in terms of 
scope, research and breeding activities which were previously widely 
possible might become more restricted. In some cases this could even 
impact traditional uses in the country of origin. Due to the short history of 
applying patents to AnGR, there is an absence of case law and scholars 
commenting on how these general principles of law will be applied in this 
particular area. In this context, this study has identified four questions 
that may raise particular problems in the future.  
6.6.1 Prior Art 
The concept of prior art relates to what is considered as the body of 
information which cannot be patented. In principle, everything already 
known should be considered part of prior art and thus ineligible to meet 
the patent criteria. However, this is only a formal point of departure as the 
Patent Office must put this principle into practice. For an activity where 
the current practices or prior art are not necessarily published in a suffi-
ciently formal manner, there is a concern that common knowledge could 
conceivably become patent protected. To avoid such occurrences, mea-
sures could be taken to ensure that all relevant sources be covered during 
the prior art search process. Such a measure could be implemented by 
expanding the check-list for Patent Offices when they search for prior 
art.  
Although preventive publishing is often put forward as a strategy to 
ensure that common knowledge will be considered prior art, it should be 
taken into consideration that such publishing only prevents patents from 
being granted in relation to that specific and particular form of published 
information. This means that preventive publishing may prove to be less 
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effective in protecting against small adaptations to what was originally 
published. 
6.6.2 Novelty and Inventiveness 
The novelty of an invention is considered by comparing the prior art with 
the invention described in the patent claims. If these two textual sources 
are identical the novelty criterion is not met and the patent should not be 
granted. In technical areas where extensive publication is not the norm, 
the chance for meeting the novelty criterion is higher than for areas where 
there is an extensive body of publications. The livestock sector might 
thus be exposed to many patent applications meeting the patent criterion 
even if they are not particularly novel in a practical sense. The same 
elements of prior art are used to assess inventiveness. If a low level of 
inventiveness is required, a granted patent may include what was de facto 
already known or in practice. Practical measures to deal with these 
problems include the development of specific guidelines for Patent 
Offices relating to how such assessments should be conducted. Such 
specific guidelines would of course have to comply with the requirement 
in the TRIPS Agreement, which states that patent protection is granted 
without discrimination among the various technological fields. Specific 
regulation of aspects for biotechnology patents is already accepted by the 
EU Directive on Biotechnological Patents (EC/98/44). 
6.6.3 Scope of the Granted Right 
In addition to concerns regarding the above principles and the granting of 
patents, the application of the principal of equivalence may create further 
difficulties when applied to livestock sector issues. While interpreting the 
written source of the patent claim, in some countries the scope of patent 
protection is made even broader than it appears from a reading of the 
patent claims. The invention as described in the patent claims might be 
interpreted to become wider to also cover inventions that are so-called 
‘equivalent’ to the invention described in the patent claims. If such an 
expansive ‘doctrine of equivalence’ is applied, there is a chance for clos-
ing another’s possibilities to breed and/or to do research. Little attention 
has been given to this principle in patent law. It is nevertheless important, 
as it might become a significant factor in establishing broad exclusive 
rights. This will have unforeseeable consequences for AnGR. Since there 
hardly is any case-law dealing with these questions in the livestock 
sector, there is a need for a thorough, systematic legal analysis related to 
assessing how general patent law rules will apply to AnGR and breeding.  
6.6.4 Exemptions to the Patent Protection 
An additional measure for supporting the adaptation of patent law could 
involve the identification of useful exemptions that would lead to more 
balanced application of patent law vis-à-vis the livestock sector. In this 
context, it is important to note that although a patent grants the exclusive 
right to use an invention as it is described in the patent claim, Article 30 
of the TRIPS Agreement specifies that ‘countries have discretion to 
implement exemptions in the right conferred by the patent on a general 
level in the patent act’. One example of such an exemption applies to 
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plants in Europe, where the EU Patent Directive Article 11 implements a 
version of the ‘farmers’ privilege’ – i.e. the right of the farmer to reuse 
his harvest as seeds under certain specific conditions even if containing a 
patented gene. There is a similar opening for EU countries to implement 
an exemption in the animal sector. Nevertheless, surprisingly few devel-
oping countries have implemented such legitimate exemptions.  
Finally, it is also worth considering the degree to which patent protection 
is needed in practise to promote breeding, research and development in 
this sector. While the issue of increased bureaucracy is often raised as a 
counter argument to the implementation of CBD-based access legislation, 
it should also be taken into consideration that the patent application 
process and subsequent enforcement are also time consuming and 
expensive. It would therefore be useful to assess what the potential 
benefits of patent protection might be for breeding, research and 
development in this sector. This should be compared to any potential 
costs, e.g. increased costs of breeding material and reduced exchange and 
use of AnGR.  
6.7 A Sui Generis System  
The term ‘sui generis’ is not a clearly defined legal term and concept in 
international intellectual property law. The TRIPS Agreement talks about 
‘an effective sui generis system’ for the protection of plant varieties as an 
alternative to providing patent protection to the same subject matter. But 
the TRIPS Agreement does not itself define such a system ‘of its own 
kind’ – a sui generis model for plant variety protection. One example of 
such a sui generis system for the protection of plant varieties are the plant 
breeders’ rights under the different versions of the UPOV Convention. 
Sui generis systems for traditional knowledge have also been on the 
agenda in WIPO for some years, but agreement on such an international 
system is still far off. If a sui generis system for AnGR shall be devel-
oped, it is crucial that the differences between plants and animals are 
carefully taken into account. 
For AnGR it is not immediately apparent which subject matter requires 
further intellectual property protection. Where such a subject matter is 
found and could be protected within the context of a sui generis system, 
then there is still a need to clarify inter alia i) who needs protection, ii) 
which entity should be the holder beneficiary to the right, iii) what should 
be the criteria for achieving protection, and iv) what should be included 
under the exclusive right. In the following section a number of options for 
sui generis protection are discussed. 
6.7.1 Animal Variety or Breed Protection  
In considering the application of an intellectual property right such as a 
sui generis system for AnGR or the breeding sector, defining the precise 
subject matter that should be protected by the right is clearly important. 
Compared to plant variety protection, providing intellectual property 
protection for ‘animal varieties/breeds’ would not make much sense. The 
variety/breed is probably not the most relevant entity in animal breeding, 
but rather the individual breeding animal or its germplasm. Furthermore, 
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the concept of an animal variety/breed is not easily defined. Such consid-
erations mean that in terms of development of a sui generis system for the 
livestock sector, it would be difficult to identify characteristics that could 
serve as a standard description of the ‘subject matter’. Further work is 
required to clarify the relevant subject matter for protection.  
6.7.2 Establishment of Breed Associations 
A sui generis system could be linked to eligibility for being registered in 
a particular register or herd book (managed by a breed association). 
Under such a sui generis protection system, registration would lead to the 
establishment of a right and the criteria for being granted that right are 
those required for being registered. The difficult question here is what the 
rights (and legal consequences) conferred by such a registration should 
entail. For example, should such a registration give any exclusive rights 
to the genetic material? One alternative could be that registration gives 
rights to the individual animal. However, such a registration would not 
add much in addition to the already held physical property right over the 
animal plus the complete genome of the particular animal in question. A 
second alternative could be that registration of individual animals also 
confers an exclusive right to single genes or alleles in the registered 
animals. This alternative is however problematic, as single genes or 
alleles often occur in a similar form in different individual animals and 
there is a need to avoid creating competing exclusive rights to the same 
gene. A third alternative could be that only those farmers and breeders 
with animals registered by the breed association have the right to use the 
name or brand of the breed. Such a ‘sui generis protection’ would be 
more similar to a regular Trademark approach. Establishment of breed 
associations or herd book registration (governed by breeding laws) com-
bined with Trademark protection would be a good alternative for breed 
conservation and property right protection.  
6.7.3 Rights to Genetic Material of Individual Animals 
One might also think about establishment of a sui generis right to the 
genetic material of the individual animal. With reference to the second 
alternative in the preceding paragraph, the first problem of such a right is 
the parallel occurrence of similar or identical genes and alleles in other 
animals. This would either undermine the exclusivity of such a right or 
result in competing property right claims. Establishing a general sui 
generis right to the genes of the individual animal would probably not 
bring much new compared to ownership of the animals. 
6.7.4 Geographical Related Properties 
A sui generis protection could also be linked to special geographical 
related properties and characteristics of the animals or their products 
(geographical indications). A final alternative for a sui generis system 
would be to leave it to the breeder to characterise in a sufficiently precise 
manner as to what s/he claims as an exclusive right. This could then be 
used to establish a system for securing rights to technological develop-
ments and provide, for example, protection for a single gene when iso-
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lated and described. Such protection is however covered by the existing 
patent system.  
To sum up, there are a number of relevant subject matters for intellectual 
property protection:  
• at the level of the individual animal – protection is conferred by 
physical ownership of that animal and/or its offspring. Rights 
transferred during the purchase/sale of individual animals can be 
protected through the use of contracts. 
• at the breed level – protection through the establishment of breed 
associations and the use of trademarks may be appropriate; 
• at the allelic, gene or protein level – protection would be covered by 
patent law; 
• regarding technical inventions relevant for breeding – protection 
would be covered by current patent law. 
6.8 Livestock Keepers’ Rights or Farmers’ Rights 
One approach in the further development of policies or regulations is to 
address the issue of whether particular groupings of stakeholders are in 
need of an improved legal or regulatory environment. In the plant sector 
the assignment of property rights (Plant Breeders’ Rights - PBRs) at the 
retail end of the pharmaceutical and plant breeding industries have tended 
to create incentives to invest at that end of the industry but not in the 
earlier parts (i.e. the genetic resource providers sector). This has had an 
impact on both efficiency and equity within the plant sector. ‘Farmers’ 
Rights’ (see the comprehensive study summarized by Andersen, 2006) 
have been proposed as a form of counterbalance to PBRs, leading to the 
protection of traditional knowledge and equitable participation in benefit 
sharing. For the livestock sector the concepts of farmers’ rights or 
livestock keepers’ rights are worth analysing in more depth. 
Livestock keepers’ rights or farmers’ rights are unexplored legal or poli-
tical concepts in the livestock sector. The term ‘farmers’ rights’ is men-
tioned in Article 9 of the ITPGRFA (FAO International Treaty on Plant 
Genetic Resources for Food and Agriculture). Farmers’ rights ‘recognize 
the enormous contribution’ farmers have made regarding plant genetic 
resources (PGR). Responsibility for realizing such rights rests with the 
national governments and there is a clause specifying that article 9 shall 
not limit any already existing ‘rights that farmers have to save, use, 
exchange and sell farm-saved seed/propagating material, subject to 
national law’. From a legal point of view, these ‘rights’ are not 
formulated in a legally binding sense, which raises issues about their 
enforcement in practice.  
Implementing a version of farmers’ rights for livestock keepers (e.g. as 
formulated in such documentation as the ‘Karen Declaration’, which 
includes support for indigenous knowledge remaining in the public 
domain and that AnGR be excluded from IPR claims) would first require 
similar international recognition of their crucial role and contribution to 
AnGR.  
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Different strategies have been suggested for securing livestock keepers’ 
rights, and these include codifying the customary laws that relate to the 
management of AnGR. A first step in this direction would be to review 
relevant customary law in order to identify which principles need to be 
included. Given that grazing rights are crucial to maintaining pastoral 
societies and are thus closely linked to conservation both at a breed level 
and at an allelic level, livestock keepers’ rights could include production 
and grazing rights, as well as the protection of traditional knowledge. 
Mechanisms to strengthen livestock keepers’ understanding of AnGR 
issues, their negotiation capacity and access to legal support would also 
necessarily be a crucial element of a strategy for developing livestock 
keepers’ rights.  
Obstacles to the implementation of livestock keepers’ rights are that they 
could conflict with other intellectual property rights. For example, if a 
patent on a particular gene existed, the consent of the patent holder could 
be required when animals that express that gene were used for further 
breeding. Addressing this potential conflict is not however an insurmoun-
table problem. For example, India has developed a Farmers’ Rights law 
which carefully balances these rights for crop seeds. Similarly, where 
livestock keepers’ rights could potentially conflict with other intellectual 
property rights, there would be a need to have rules for how these 
interests should be taken into account within the highly specified and 
enforceable body of patent law. One approach would be that livestock 
keepers’ rights could inter alia be relevant for inclusion both when 
assessment of the patent criteria is carried out, as well as during 
enforcement. Livestock keeper practises are typically not published in a 
manner qualifying as prior art according to the patent system. Two 
alternative approaches also might be considered: i) either single countries 
could implement exemptions to intellectual property rights for livestock 
keepers, or ii) standard exemptions could be developed at a regional or 
multilateral level.  
It is also possible to imagine some form of a sui generis protection 
system for livestock keepers’ rights. This concept would have to be 
developed further on a theoretical level, as suggested elsewhere in this 
study, but could include a model for benefit sharing or could combine 
individual and community rights over AnGR. A crucial issue in the 
development of such a concept would be whether a sui generis system 
should include a positive right to exclude others or whether it should be 
geared towards being a negative right aiming at preventing 
misappropriation of what is in use by livestock keepers. 
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